Aspirin for cardioprotection and strategies to improve patient adherence.
Publication/Presentation Date
1-1-2014
Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in North America. Aspirin therapy has proven clinical effectiveness in the prevention and treatment of CVD and is one of the most widely used drugs nationwide. However, despite the medication's popularity and utility, adherence to a proper aspirin regimen is suboptimal, resulting in adverse health outcomes and increased health care costs. Our review outlines current knowledge on aspirin therapy adherence, causes of nonadherence, and strategies available to increase adherence to aspirin and medications in general. We demonstrate that, indeed, aspirin adherence rates are suboptimal, ranging from 72% to 92%, and that a combination of patient- and medication-related factors contribute to nonadherence. A multidimensional approach involving patient education and medication innovations to reduce aspirin side effects is imperative to improving rates of aspirin therapy adherence.
Volume
126
Issue
1
First Page
18
Last Page
28
ISSN
1941-9260
Published In/Presented At
Duffy, D., Kelly, E., Trang, A., Whellan, D., & Mills, G. (2014). Aspirin for cardioprotection and strategies to improve patient adherence. Postgraduate medicine, 126(1), 18–28. https://doi.org/10.3810/pgm.2014.01.2721
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
24393748
Department(s)
Administration and Leadership
Document Type
Article